Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity
Fatma A. Mohamed, Hesham A. M. Gomaa, Omnia M. Hendawy, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104960-104960
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism
Mohammed A. S. Abourehab, Alaa M. Alqahtani, Bahaa G. M. Youssif, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6677-6677
Open Access | Times Cited: 125
Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities
Hesham A. M. Gomaa, Mohamed E. Shaker, Sami I. Alzarea, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105616-105616
Closed Access | Times Cited: 44
Discovery of new pyrimido[5,4-c]quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies
Ramadan Ahmed Mekheimer, Samar M R Allam, Mariam A. Al‐Sheikh, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105693-105693
Closed Access | Times Cited: 39
Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship
Keshav Taruneshwar Jha, Abhimannu Shome, Chahat, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106680-106680
Closed Access | Times Cited: 28
Design, synthesis, and antiproliferative properties of new 1,2,3-triazole-carboximidamide derivatives as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Molecular Structure (2023) Vol. 1282, pp. 135165-135165
Closed Access | Times Cited: 24
Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 10
Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 35
Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors
Mohamed Hisham, Heba A. Hassan, Hesham A. M. Gomaa, et al.
Journal of Molecular Structure (2022) Vol. 1254, pp. 132422-132422
Closed Access | Times Cited: 33
Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 27
Synthesis and biological assessment of indole derivatives containing penta-heterocycles scaffold as novel anticancer agents towards A549 and K562 cells
Guanglong Zhang, Zhenhua Tang, Sili Fan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 15
Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Eman A. M. Beshr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9104-9104
Open Access | Times Cited: 15
Synthesis and Anticancer Activities of Pyrazole–Thiadiazole-Based EGFR Inhibitors
Berkant Kurban, Begüm Nurpelin Sağlık, Derya Osmani̇ye, et al.
ACS Omega (2023) Vol. 8, Iss. 34, pp. 31500-31509
Open Access | Times Cited: 15
A Concise Review on Recent Development of Indole Derivatives for Anticancer Activities
B. T. Sridhar, Nagesh Gunavanthrao Yernale, Ramesh S. Gani, et al.
Journal of the Indian Chemical Society (2024) Vol. 101, Iss. 10, pp. 101282-101282
Closed Access | Times Cited: 6
Epidermal Growth Factor Receptors Unveiled: A Comprehensive Survey on Mutations, Clinical Insights of Global Inhibitors, and Emergence of Heterocyclic Derivatives as EGFR Inhibitors
Chandramouli Manojmouli, T. Y. Pasha, Mohamed Rahamathulla, et al.
Journal of drug targeting (2025), pp. 1-19
Closed Access
Therapeutic Insights of Indole Scaffold‐Based Compounds as Protein Kinase Inhibitors
Dina H. Dawood
ChemistrySelect (2025) Vol. 10, Iss. 5
Open Access
New antiproliferative 1,3,4-oxadiazole/benzimidazole derivatives: Design, synthesis, and biological evaluation as dual EGFR and BRAFV600E inhibitors
Fatma Fouad Hagar, Samar H. Abbas, Ahmed M. Sayed, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108297-108297
Closed Access
Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity
Bahaa G. M. Youssif, Ahmed M. Gouda, Amr H. Moustafa, et al.
Journal of Molecular Structure (2021) Vol. 1253, pp. 132218-132218
Closed Access | Times Cited: 38
Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: Design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis induction and dual EGFR/Topo-1 inhibition
Peter A. Halim, Souty M.Z. Sharkawi, Madlen B. Labib
Bioorganic Chemistry (2022) Vol. 131, pp. 106273-106273
Closed Access | Times Cited: 25
A comprehensive review of recent advances in the biological activities of 1,2,4‐oxadiazoles
Omnia M. Hendawy
Archiv der Pharmazie (2022) Vol. 355, Iss. 7
Closed Access | Times Cited: 23
Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAFV600E
Mohammed B. Alshammari, Ashraf A. Aly, Bahaa G. M. Youssif, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 23
Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 14
A comprehensive review of recent advances in the biological activities of quinazolines
Hesham A. M. Gomaa
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 639-655
Closed Access | Times Cited: 18
Design, synthesis and antimicrobial activity of novel quinoline-2-one hybrids as promising DNA gyrase and topoisomerase IV inhibitors
Mohammed A. I. Elbastawesy, Fatma A. Mohamed, Islam Zaki, et al.
Journal of Molecular Structure (2023) Vol. 1278, pp. 134902-134902
Closed Access | Times Cited: 11
Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3- (2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFR WT/ EGFR T790M inhibitors
Lamya H. Al-Wahaibi, Anber F. Mohammed, Fatema El-Zahraa S. Abdel Rahman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top